73604-914 : Arcalyst 160 mg/2ml Subcutaneous Injection, Powder, Lyophilized, for Solution


NDC: 73604-914
Labeler: Kiniksa Pharmaceuticals (Uk), Ltd.
Product Type: Human Prescription Drug
Drug Name:  Arcalyst
Dosage Form: Subcutaneous Injection, Powder, Lyophilized, for Solution
Application #: BLA125249
Rev. Date: 


NDC Package Codes:

  • 73604-914-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (73604‑914‑01) > 2 ML IN 1 VIAL, SINGLE‑USE
  • 73604-914-04: 4 VIAL, SINGLE‑USE IN 1 CARTON (73604‑914‑04) > 2 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Rilonacept

Dosage Strength:

  • 160 mg/2mL

Related Products:

Based on records with the same trade name.
  • 61755-001 Arcalyst 160 mg/2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Regeneron Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 73604-914 QR Code

< Prev: 73603-000Next: 73606-010 >

Related Discussions:

Rilonacept
Clinical trial for gout treatment. Is it safe? Who has been on it for any reason and what did they think of it?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.